Orlistat is blocking some of the fat that you eat, keeping it from being absorbed by your body. Orlistat is used to aiding in weight loss and it is helped to reduce the risk of regaining weight already lost. This medicine is must be used together with a reduced-calorie diet and it is increased physical activity. Orlistat is used for only adults that are overweight or obese. Orlistat powder manufacturer is a drug available in prescription and over-the-counter that promotes weight loss. Side effects are including abdominal pain and discomfort, oily or fatty stools, gas (flatulence), oily spotting on underwear. Drug interactions, dosing, and pregnancy and breastfeeding safety information should be reviewed before taking any OTC or prescription medication.
The dosage for orlistat
Orlistat powder manufacturer is the prescription-strength form of orlistat. This is available without a prescription. Dietary fats are needed to be broken down into smaller pieces before the body can absorb them. Orlistat is working by blocking the enzyme that breaks down fats in your diet. This undigested fat is passed out of your body in your bowel movement. So you are still needed to restrict your total intake of calories.
- The recommended prescription dose for Xenical is one of the capsules that is taking (120 mg) three times daily.
- The recommended dose for Orlistat is 60 mg three times daily.
- Orlistat is taking one hour after or during a meal containing about 15 mg of fat. Meals without fat do not require orlistat.
- No additional benefit has been shown when orlistat is taken in doses greater than 120 mg.
- Patients should eat a nutritionally balanced, reduced-calorie diet that is containing approximately 30% of calories from fat.
- This is including an individually tailored online weight loss support program.
Supplements of Orlistat
- The blood-thinning effect of warfarin is depending on the amount of vitamin K in the body, and vitamin K is one of the vitamins that is binding to fat.
- Patients are receiving warfarin who are beginning orlistat should have their blood clotting monitored closely because the orlistat may cause levels of vitamin K to decline.
- This will be increased the effects of warfarin and lead to abnormal bleeding from the warfarin.
- There is no evidence that a deficiency of vitamin K is occurring in patients who are taking orlistat.
- Orlistat may be reducing the absorption and blood levels of cyclosporine (Sandimmune) when both drugs are administered together.
- Therefore, cyclosporine is administered two hours before or after orlistat, and more frequent monitoring of cyclosporine levels may be needed.
- Hypothyroidism has been reported when this orlistat and levothyroxine (Synthroid, Levoxyl, Levothroid, Unithroid) were combined.
- Patients are treated with both orlistat and levothyroxine should be monitored for changes in thyroid function from cetilistat manufacturer. The orlistat and levothyroxine are taking at least four hours apart.